Navigation Links
MedServe to be Acquired by Stericycle for $185 Million
Date:5/14/2009

HOUSTON, May 14 /PRNewswire/ -- MedServe, Inc., a private company, today announced that it has entered into an agreement to be acquired by Stericycle, Inc. (Nasdaq: SRCL) for $185 million in cash.

MedServe has been majority-owned by Avista Capital Partners, Chrysalis Ventures and Murphree Venture Partners since September 2006. MedServe is engaged in the collection, transportation, treatment and disposal of medical waste, hazardous waste, universal waste and other regulated wastes; sharps management services; safety and compliance training services; and other related businesses.

Roger Ramsey, Chairman and Chief Executive Officer of MedServe, said, "We would like to thank Avista, Chrysalis, Murphree and our other shareholders for their commitment to MedServe over the last three years. We are grateful for their support of the company's strategic vision and assistance in achieving this successful event.

"Most importantly, I would like to express my appreciation for MedServe's talented, dedicated and experienced employees. It is through their hard work that our company has experienced such rapid growth in the U.S."

Steve Webster, Co-Managing Partner of Avista, said, "MedServe has made significant progress during the period of Avista, Chrysalis and Murphree's ownership. The company has grown into a great business with an exceptional base of employees. The entire investor group is delighted to have sponsored MedServe and that we were able to partner with the company's outstanding management team."

The transaction is subject to customary closing conditions and regulatory reviews, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

About MedServe

MedServe, Inc., headquartered in Houston, Texas, is engaged in the collection, transportation, treatment and disposal of medical waste, hazardous waste, universal waste and other regulated wastes; sharps management services; safety and compliance training services; and other related businesses. For additional information about MedServe, please visit www.medserve.com.

About Avista Capital Partners

Founded in 2005, Avista Capital Partners is a leading private equity firm with offices in New York, NY and Houston, TX. Avista's strategy is to make controlling or influential minority investments primarily in growth-oriented energy, healthcare and media companies. Through its team of seasoned investment professionals and industry experts, Avista seeks to partner with exceptional management teams to invest in and add value to well-positioned businesses. For more information, visit www.avistacap.com.

About Chrysalis Ventures

Founded in 1993, Chrysalis Ventures is the premier venture capital firm in Mid-America, managing one of the region's largest funds for early-stage and growth investments. Chrysalis invests primarily in early-stage and expansion-stage companies in healthcare services and technology, media and communications, and emerging trends and technologies. Based in Louisville, Kentucky, Chrysalis has approximately $400 million under management and has made investments in 60 companies. For more information, visit www.chrysalisventures.com.

About Murphree Venture Partners

Murphree Venture Partners is a venture capital/private equity firm that makes investments in entrepreneurial enterprises with high-growth potential. Murphree seeks to align itself with entrepreneurs and management groups with whom it can develop strong working relationships, and with whom it can act in concert as owners/investors. Murphree invests in the Sun Belt region of the U.S. from its four offices in Houston, Austin, Baton Rouge and Birmingham. For more information, visit www.murphco.com.

    Media Contact
    Diana Postemsky, Kekst and Company, 212-521-4805


'/>"/>
SOURCE MedServe, Inc.; Avista Capital Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Meritain Health Announces Name Change for Acquired Companies
2. Aspreva to be Acquired by Galenica For US$915 Million
3. Alarming MRSA Infection Rates Underscore Need for Public Reporting of Hospital-Acquired Infections
4. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
5. Microflex(R) Corporation Acquired by Linden and Edgewater
6. MicroActive Corporation Acquired by Linden and Edgewater
7. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
8. Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
9. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
10. HTG-Ventrex, Signalifes Contract Manufacturer, Acquired by Parker Hannifin Corporation
11. Gender disparity in community-acquired pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Interest is on the rise ... and as an orthogonal tool for RNAi hit validation. A key reason may be ... RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview on The Greenburgh Report ... Rochelle, NY-based WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross ... “modern medical money maelstrom.” , During the interview with Mr. Feiner that aired ...
(Date:5/31/2016)... IL (PRWEB) , ... May 31, 2016 , ... ... multichannel marketing services firm and statement solutions provider, for the tenth ... in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in ...
(Date:5/31/2016)... ... ... Super Powder, a supplement produced by Prox Formulas for providing protein ... to transform the nutritional supplement industry by providing a safe, natural approach to enhanced ... (BCAA), alkaline minerals, wheat grass, digestive enzymes, Omega 3’s, Vit D3, Vit A, B1, ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, the leader ... an original infographic, " Health Benefits Reimbursement Compliance Timeline ." , The ... complies with various federal regulations and reforms. , Navigating the new health reforms ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology: